CS logo
small CS logo
Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum

Essen, Germany
Women's health clinic in Essen, North Rhine-Westphalia
Henricistraße 92, 45136 Essen

About Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
12
West German Study Group
3
Genentech, Inc.
2
Breast International Group
1
Daiichi Sankyo, Inc.
1
Dompé Farmaceutici S.p.A
1
Institut de Recherches Internationales Servier
1
Pfizer
1
Total Rows: 8

Clinical Trials at Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum


During the past decade, Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 10 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111222255111100222222111111Started TrialsCompleted Trails20162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer
2009-10-29
2014-07-09
Completed
361

Rows per page:

1–22 of 22

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "West German Study Group" with 3 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Breast International Group" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Genomic Health®, Inc." with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 12Hoffmann-La Roche: 12West German Study Group: 3West German Study Group: 3Genentech, Inc.: 2Genentech, Inc.: 2Breast International Group: 1Breast International Group: 1Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1Dompé Farmaceutici S.p.A: 1Dompé Farmaceutici S.p.A: 1Institut de RecherchesInternationales Servier:1Institut de RecherchesInternationales Servier:1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsBreast International Group: 2Breast International Group: 2Genomic Health®, Inc.: 2Genomic Health®, Inc.: 2German Breast Group: 2German Breast Group: 2NSABP Foundation Inc: 2NSABP Foundation Inc: 2AstraZeneca: 1AstraZeneca: 1Austrian Breast andColorectal CancerGroup: 1Austrian Breast andColorectal CancerGroup: 1Breast EuropeanAdjuvant Studies Team:1Breast EuropeanAdjuvant Studies Team:1Chugai Pharmaceutical: 1Chugai Pharmaceutical: 1Eli Lilly and Company: 1Eli Lilly and Company: 1Frontier Science &Technology ResearchFoundation, Inc.: 1Frontier Science &Technology ResearchFoundation, Inc.: 1

Clinical Trials Conditions at Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum


According to Clinical.Site data, the most researched conditions in "Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum" are "Breast Cancer" (8 trials), "Breast Cancer Female" (2 trials), "Breast Neoplasms" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Triple-Negative Breast Cancer" (2 trials). Many other conditions were trialed in "Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum


Most popular intervention types in "Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum" are "Drug" (21 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Atezolizumab" (6 trials), "Paclitaxel" (4 trials), "Cyclophosphamide" (3 trials) and "Doxorubicin" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum


The vast majority of trials in "Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum" are 16 trials for "All" genders and 6 trials for "Female" genders.

Clinical Trials Status at Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum


Currently, there are NaN active trials in "Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum, 1 suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 14Phase 3: 14Phase 2: 7Phase 2: 7Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Recruiting: 7Recruiting: 7Active, not recruiting: 3Active, not recruiting: 3Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1